慢性肾脏病(CKD)在我国成年人中的发病率约为10.8%[1],已成为影响人类健康的公共卫生问题。血脂异常是慢性肾脏病常见的并发症,发病率高达40%[2-3]。有文献报道,其可以加重肾功能恶化,也可能是CKD患者罹患心血管疾病(CVD)的一个独立危险因素。目前,有关血脂异常与CKD进展关系的研究还不够深入,业内也存在一定争议。现就CKD患者血脂异常与疾病进展相关研究综述如下。 The incidence of chronic kidney disease (CKD) among adults in China is about 10.8% [1], which has become a public health problem affecting human health. Dyslipidemia is a common complication of chronic kidney disease, the incidence of up to 40% [2-3]. It has been reported in the literature that it may exacerbate renal dysfunction and may also be an independent risk factor for cardiovascular disease (CVD) in CKD patients. At present, the study on the relationship between dyslipidemia and CKD progress is not deep enough, there is also some controversy in the industry. Now CKD patients with dyslipidemia and disease progression related research are summarized below.